Type 1 Diabetes & Heart Health: Is Bypass Surgery the Best Strategy?
"New research sheds light on why coronary artery bypass grafting (CABG) might be superior to stents (PCI) for individuals with type 1 diabetes and complex heart disease."
For individuals grappling with aggressive coronary artery disease (CAD), deciding between coronary artery bypass grafting (CABG) and percutaneous intervention (PCI, or stenting) is a critical decision. A growing body of evidence suggests CABG may offer superior long-term survival and reduce the risk of heart attack, especially when CAD is extensive.
Severity often depends on the extent and complexity of CAD, which doctors measure using the SYNTAX score. The presence of diabetes, particularly type 1 diabetes (T1DM), further complicates matters. Studies indicate that CABG tends to yield better results than PCI in these higher-risk scenarios, regardless of whether older balloon angioplasty, bare-metal stents, or newer drug-eluting stents are used.
Now, new research focuses specifically on individuals with type 1 diabetes (T1DM), a group often underrepresented in previous trials that largely focused on type 2 diabetes (T2DM). This article explores why CABG might be a more effective strategy for people with T1DM and complex CAD, diving into the underlying mechanisms and latest evidence.
The Cardiovascular Burden
In the United States, 4.9% of adults had ever been diagnosed with coronary heart disease in 2022, according to CDC data. Physician offices recorded 13.0 million visits with coronary atherosclerosis and other chronic ischemic heart disease as the primary diagnosis. A review reports that by age 55, the cumulative mortality rate from coronary artery disease among people with type 1 diabetes was 35%, compared with 8% among men and 4% among women without diabetes in the Framingham Heart Study.
Risk Assessment Remains Complex
Coronary artery calcium is used as a marker of atherosclerotic cardiovascular disease, but its relationship with type 1 diabetes-specific cardiovascular risk-stratification tools remains uncertain. Cardiovascular disease is the main cause of morbidity and reduced life expectancy in people with type 1 diabetes mellitus, while coronary artery disease is its main cardiovascular manifestation. The CaRe-T1D initiative highlights the need to better understand disease-specific differences in atherosclerosis, acute myocardial infarction outcomes, myocarditis, coronary microangiopathy, and heart failure patterns.
How Diabetes Risk Became Established
Longitudinal research summarized in a 2025 review found that diabetes significantly increases the risk of cardiovascular disease, particularly coronary artery disease and stroke. The same review reports a threefold increase in cardiovascular mortality among people with diabetes, reinforcing the importance of cardiovascular risk management. More recent CaRe-T1D findings indicate that among asymptomatic patients of similar age, coronary artery disease was more extensive in type 2 diabetes than in type 1 diabetes, with more total, obstructive, and noncalcified lesions.
Why Complexity Matters: The SYNTAX Score and CABG's Advantage
One consistent theme emerges when comparing CABG and PCI: CABG's benefits become more pronounced as the complexity and extent of CAD increase. The SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score helps quantify this complexity, guiding treatment decisions.
- SYNTAX Score: A tool to categorize the complexity of coronary artery disease.
- Low Score (≤22): Indicates less complex disease.
- Intermediate Score (23-32): Suggests moderate complexity.
- High Score (≥33): Represents highly complex disease.
CABG and PCI in Diabetes
Recent discussion of type 1 diabetes emphasizes that coronary disease complexity is relevant when selecting a revascularization strategy. Reviews note that people with diabetes often have comorbidities such as hypertension, peripheral artery disease, renal disease, and heart failure, and may experience stent-related complications including thrombosis, neoatherosclerosis, and restenosis. In the FREEDOM Follow-On Study, spontaneous myocardial infarction and repeat revascularization for new lesions were significantly more common after PCI than after CABG in patients with diabetes, findings proposed as part of CABG's benefit in diffuse atherosclerosis.
CABG vs. PCI: The Verdict for Type 1 Diabetes
The study by Nyström et al. reinforces the idea that CABG may be particularly beneficial for individuals with T1DM and multivessel CAD. Their research, analyzing a large cohort of patients in Sweden, revealed that CABG was associated with superior outcomes compared to PCI in terms of heart-related mortality, heart attack, and heart failure.
Targeting Residual Risk
A 2025 study reports that aging people with long-duration type 1 diabetes can retain a high burden of coronary atherosclerosis even without diabetic kidney disease and despite excellent cardiometabolic management. The findings identify improving hyperglycemia and mitigating inflammation, particularly inflammation involving osteopontin, as potentially important approaches to cardiovascular disease management. This suggests that future strategies may need to address residual vascular and inflammatory risk beyond conventional cardiometabolic control.
A Lifelong Management Challenge
A diagnosis of type 1 diabetes requires frequent blood-sugar monitoring and insulin-dose adjustments to prevent acute complications. It also creates a continuing need to prevent long-term complications, with cardiovascular disease representing the foremost long-term burden in terms of total impact and mortality. This combination makes heart-health management a lifelong challenge rather than an issue addressed only when coronary disease becomes severe.
While this study offers valuable insights, it's important to acknowledge its limitations as an observational study. The PCI group, for instance, tended to be older and have more pre-existing conditions, potentially influencing the results. These factors highlight the challenges of comparing treatments in non-randomized settings.
Ultimately, the decision between CABG and PCI should be made on an individual basis, considering the complexity of CAD (SYNTAX score), the presence of diabetes (especially T1DM), and other patient-specific factors. The growing body of evidence, including the findings, suggests CABG may offer a significant survival advantage for individuals with T1DM and complex coronary disease.